What if Federal Marijuana Reform Doesn’t Happen Anytime Soon? Part 1 October 10, 2022 AggregatedNews Federal 1 Comment By Jesse Mondry, Attorney at Harris Bricken The Oregon marijuana industry is hurting, much like industry in California and other states. Among the many reasons (overproduction, market saturation) is that federal marijuana laws have not been reformed at all. For… Read More→
The Good The Bad and The Ugly, What Europe Can Learn from the U.S. and Canadian Cannabis Industries November 9, 2020 Michael Sassano Europe, Op-Ed 0 Comments Europe has a lot to learn from the U.S. and Canada as it transforms: the good, the bad, and the ugly. Cannabis not only has proven medical benefits but financial benefits to both consumers and countries that benefit from greater… Read More→
It’s Far’s Far Too Soon To Think About Celebrating The Legitimacy of Cannabis Because The War On Pot Is Still Raging April 17, 2019 Doug Poretz News & Insights, Opinions 0 Comments By Doug Poretz The kneejerk reaction to a discussion about the cannabis industry is to be jubilant. After all, we see high growth among a wide segment of players from growers to lighting companies, a virtual tsunami of all sorts of… Read More→
5 Big Predictions for Cannabis This Year March 21, 2019 AggregatedNews News & Insights 0 Comments Big pharma, microdosing and inter-state commerce are among some trends to watch. Opinions expressed by Green Entrepreneur contributors are their own. Just a few months into 2019, and it’s proving to be another wild year for the cannabis industry. More… Read More→
Big Pharma is Coming for the Cannabis Industry January 5, 2019 John Taenzler Medical Marijuana, Science and Technology 0 Comments In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or… Read More→
Former Big Pharma Exec Makes the Switch From OxyContin to Marijuana November 29, 2016 AggregatedNews Industry People, On the Move 1 Comment John Stewart used to run the pharmaceutical company behind the narcotic painkiller OxyContin. Now he is banking on medical marijuana. Mr Stewart does not know which is more controversial these days, OxyContin or pot. He guesses the average person would… Read More→
DEA and Big Pharma: The Tangled Web of the Opioid Crisis October 10, 2016 Ralph Morgan Opinions, The Buck Stops Here 1 Comment By Ralph Morgan Cannabis Industry leaders and activists are seemingly the only two groups with a sense of urgency to find a reasonable alternative pain remedy to replace synthetic opioids. Pharmaceuticals are responsible for a death every 19 minutes. Big… Read More→
Big Pharma Seeks to Capitalize on Pain-Reducing Compound Derived From Cannabis August 24, 2016 AggregatedNews Science and Technology 0 Comments The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma -- not to… Read More→
Big Pharma Expresses Interest in Medical Cannabis August 15, 2016 AggregatedNews News & Insights 0 Comments At least once a week, Steve McDonald drives from his home in Irvine to an industrial stretch of Santa Ana filled with auto shops and home-improvement wholesalers. Inside a beige storefront, McDonald consults with young budtenders about the jars of… Read More→
One Thing Is Clear: Big Pharma Does Not Want Legalization July 14, 2016 AggregatedNews News & Insights 0 Comments There's a body of research showing that painkiller abuse and overdose are lower in states with medical marijuana laws. These studies have generally assumed that when medical marijuana is available, pain patients are increasingly choosing pot over powerful and deadly prescription… Read More→